referral centers than at low-volume community hospitals have prompted calls for regionalizing pancreaticoduodenectomy (the Whipple procedure). We examined the relationship between hospital volume and mortality with this procedure across all US hospitals.
Methods: Using information from the Medicare claims database, we performed a national cohort study of 7229 Medicare patients more than 65 years old undergoing pancreaticoduodenectomy between 1992 and 1995. We divided the study population into approximate quartiles according to the hospital's average annual volume of pancreaticoduodenectomies in Medicare patients: very low (<l/y), low (1-2/y), medium (2-5/y), and high (5+/y). Using multivariate logistic regression to account for potentially confounding patient characteristics, we examined the association between institutional volume and in-hospital mortality, our primary outcome measure.
Results: More than 50% of Medicare patients undergoing pancreaticoduodenectomy received care at hospitals performing fewer than 2 such procedures per year. In-hospital mortality rates at these low-and very-low-volume hospitals were 3-to 4- [5] . Finally, a recent publication by Simunovic and colleagues, who investigated postoperative mortality after pancreatic resection in Canadian publicly funded hospitals, reported a 3.4% mortality in high volume hospitals i.e., those performing more than 42 resections in the 6-year period of the study [6] , compared with a 14.4% mortality in low volume hospitals.
Such international and national surveys appear to reinforce the high volume: low mortality message. However, another important publication has been omitted from the authors argument, which is the paper by Wade and colleagues relating to the treatment of periampullary cancer in the US Department of Defence hospitals [7] . In this study the 
